Medtronic vs Globus Medical: Who Leads US Spine in 2026

Medtronic vs Globus Medical
Medtronic vs Globus Medical is the defining rivalry in the U.S. spine market in 2026.

Medtronic leads the U.S. spinal implant and VCF market, Globus Medical ranks second, and DePuy Synthes ranks third, according to iData Research.

The market was valued at nearly $6.4 billion in 2025.

Medtronic wins on breadth, while Globus Medical wins the interbody device segment and keeps gaining share in fixation.

Here is where each company leads, how their spine robots compare, and what could change the ranking.

Find growth niches in minutes, not months.

Explore quick, actionable insights from the select markets.

Get a Free Report Summary

Table of Contents

➜ Who leads the US spine market in 2026?

➜ Why Medtronic leads the US spine market

➜ How Globus Medical became the No. 2 US spine company

➜ Medtronic vs Globus Medical: who wins each spine segment?

➜ Medtronic vs Globus Medical in robotics: Stealth AXiS or ExcelsiusGPS?

➜ Can Globus Medical overtake Medtronic in spine?

➜ Frequently asked questions

Key Takeaways

  • Medtronic is the largest U.S. spine company, with first place in cervical fixation, thoracolumbar fixation, and vertebral compression fracture (VCF) devices.
  • Globus Medical is the No. 2 U.S. spine company and the leader in interbody devices.
  • The U.S. spinal implant and VCF market was worth nearly $6.4 billion in 2025 and is forecast to reach $7.3 billion at a 1.9% CAGR.
  • In robotics, Medtronic vs Globus Medical comes down to Stealth AXiS against ExcelsiusGPS.
  • Globus Medical’s U.S. spine growth slowed to about 2% in Q3 2026, which gives Medtronic room to defend its lead.

Who leads the US spine market in 2026?

Medtronic leads the U.S. spine market, and Globus Medical is the clear No. 2.

iData Research ranks DePuy Synthes third overall.

iData Research forecasts the market to grow at a 1.9% CAGR to reach $7.3 billion by 2032.

Growth is driven by an aging population and more complex, multi-level cases rather than rising procedure counts.

That matters for the Medtronic vs Globus Medical race, because complex cases reward companies that sell implants, navigation, and robots together.

Why Medtronic leads the US spine market

Medtronic holds first place across more U.S. spine segments than any other company.

It leads cervical fixation, thoracolumbar fixation, and the VCF market, and ranks second in interbody devices.

The StealthStation navigation platform, O-arm intraoperative imaging, and Mazor robotic system create high switching costs for hospitals.

Medtronic says navigation now guides about 70% of U.S. spine procedures, building on an installed base of roughly 10,000 units.

On February 13, 2026, Medtronic received FDA clearance for the Stealth AXiS surgical system.

It is the first platform to combine planning, navigation, and robotics in one system for spine surgery.

Its LiveAlign segmental tracking shows spinal motion and alignment in real time without repeated imaging.

In June 2026, Medtronic said the Stealth AXiS launch helped drive low double-digit growth in its navigation business.

How Globus Medical became the No. 2 US spine company

iData Research calls Globus Medical the most commercially dynamic large spine company of the current market cycle.

Its 2023 acquisition of NuVasive expanded its product range, surgeon relationships, and sales footprint.

Since the merger closed, Globus Medical has posted significant share gains in cervical and thoracolumbar fixation, according to iData Research.

It now leads the U.S. interbody device market, ahead of Medtronic.

In Q1 2026, Globus Medical reported U.S. spine revenue of $347 million, up 10% for a third straight quarter.

Management estimated the underlying market was growing about 3%, so most of that growth came from share gains.

In its Q1 2026 report, Globus Medical announced FDA 510(k) clearances for Scripps patient-specific lumbar spacers and rods.

Its 2025 purchase of Nevro added spinal cord stimulation, a market covered in our Abbott vs Medtronic spinal cord stimulation analysis.

Orthopedic Device Market Insights - iData Research

Medtronic vs Globus Medical: who wins each spine segment?

The Medtronic vs Globus Medical matchup looks different in every segment, based on iData Research 2025 U.S. rankings.

Cervical fixation: Medtronic ranks first, DePuy Synthes second, and Globus Medical third.

Thoracolumbar fixation: Medtronic ranks first, Globus Medical second, and DePuy Synthes third.

Interbody devices: Globus Medical ranks first, Medtronic second, and VB Spine/Stryker third.

Vertebral compression fracture: Medtronic ranks first, VB Spine/Stryker second, and DePuy Synthes third.

Motion preservation: Centinel Spine ranks first, Highridge Medical second, and Globus Medical third.

Electrical stimulation: Orthofix ranks first, Highridge Medical second, and Enovis third.

In this Medtronic vs Globus Medical scorecard, Medtronic leads three segments, while Globus Medical leads one.

Each company places in the top three in four of the six segments.

Medtronic vs Globus Medical in robotics: Stealth AXiS or ExcelsiusGPS?

Robots matter in spine because they reinforce surgeon preference for the same company’s implants and instruments.

ExcelsiusGPS is Globus Medical’s main commercial differentiator and drives implant use among robot-enabled surgeons.

Globus Medical’s CEO has said the company competes mainly against Medtronic in robotics.

In Q3 2026, Globus Medical reported that ExcelsiusGPS and ExcelsiusHub units deployed were 65% higher year to date.

The FDA also closed its July 2024 warning letter on ExcelsiusGPS during that quarter.

Stealth AXiS is newer, but it builds on Medtronic’s large navigation installed base.

Clinical evidence supports the category, since a 2025 meta-analysis of 18 studies and 1,566 patients linked robot-assisted thoracolumbar surgery to better screw accuracy and fewer complications and revisions.

For the wider robotics race, see our look at Medtronic’s Hugo, da Vinci SP, and the new robotic surgery race.

Can Globus Medical overtake Medtronic in spine?

Globus Medical is unlikely to overtake Medtronic in 2026.

Its U.S. spine growth slowed to about 2% in Q3 2026, as reported in its Q3 2026 results filed with the SEC.

Management tied the slowdown to delayed new product launches and lower contributions from competitive recruiting.

Globus Medical expects those launches to drive results as they scale in the coming year.

Medtronic is early in the Stealth AXiS rollout and still leads three core segments.

The wider market is also shifting, as motion preservation devices and non-surgical options compete with fusion.

Johnson and Johnson’s October 2025 plan to spin off DePuy Synthes could add a third strong independent rival.

For 2026, the Medtronic vs Globus Medical verdict is clear: Medtronic keeps the top spot, and Globus Medical remains the company most likely to close the gap.

Turn market painpoints into opportunities

Explore how procedure trends and competitor positioning create clear openings for industry experts in the market.

Get a Free Report Summary

Frequently asked questions

Who is the largest spine company in the US?

Medtronic is the largest company in the U.S. spinal implant and VCF market, according to iData Research.

Who wins Medtronic vs Globus Medical in spine?

Medtronic wins overall, but Globus Medical leads Medtronic in the U.S. interbody device market.

What is the difference between Stealth AXiS and ExcelsiusGPS?

Stealth AXiS combines planning, navigation, and robotics in one Medtronic system, while ExcelsiusGPS is Globus Medical’s floor-mounted robotic navigation platform.

How big is the US spinal implant market?

The U.S. spinal implant and VCF market was valued at nearly $6.4 billion in 2025 and is forecast to reach $7.3 billion by 2032.

When did Globus Medical buy NuVasive?

Globus Medical acquired NuVasive in 2023, which helped make it the second-largest U.S. spine company.

Get the full Medtronic vs Globus Medical market shares and forecasts in the iData Research U.S. Spinal Implant and VCF Market Report.